Advertisement

Moderna begins process for full FDA approval of its COVID-19 vaccine

Moderna announced Tuesday that it has initiated the rolling submission process with the FDA for full approval of its COVID-19 vaccine for people 18 years and older.

Advertisement

Video above: Doctor talks about possibility of Moderna COVID-19 vaccine use in kids ages 12-15

Moderna announced Tuesday that it has initiated the rolling submission process with the Food and Drug Administration for full approval of its COVID-19 vaccine for people 18 years and older.

"We are pleased to announce this important step in the U.S. regulatory process for a Biologics License Application (BLA) of our COVID-19 vaccine," said Stéphane Bancel, Chief Executive Officer of Moderna. "We look forward to working with the FDA and will continue to submit data from our Phase 3 study and complete the rolling submission."

Moderna's vaccine already has been cleared for emergency use by the FDA and regulators in numerous other countries. So far, more than 124 million doses have been administered in the United States.

Last month, Moderna said its vaccine strongly protects kids as young as 12, a step that could put the shot on track to become the second option for that age group in the U.S. Pfizer's COVID-19 vaccine has received emergency use approval for children as young as 12.

Moderna says will continue to submit data to support the BLA to the FDA on a rolling basis over the coming weeks.